AstraZeneca · 18 hours ago
District Sales Manager, Specialty Care - Westchester, NY
AstraZeneca is a leading pharmaceutical company dedicated to turning ideas into life-changing medicines. They are seeking a District Sales Manager for the Specialty Care Cardiovascular Renal Metabolic Team to drive innovative sales strategies and enhance team performance while engaging with healthcare professionals to improve patient outcomes.
BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Demonstrate a strong understanding of the Cardiovascular Renal Metabolic pharmaceutical products, disease states, and treatment guidelines within the specialty care setting
Possess and demonstrate a solid grasp of sales metrics, market analysis, and budget management within the specialty care environment
Understand and identify HCP needs
Share insights to guide Brand Strategy
Actively engage in coaching and development of sales representatives to enhance their performance and professional growth including in field with customer engagement
Cultivate a collaborative and performance-driven team environment, setting clear expectations and providing necessary support for sales representatives to excel
Actively seek out opportunities for growth, leveraging market insights and customer feedback to drive innovative sales strategies
Enable the team to gain access via multiple selling channels across accounts, leveraging relevant technology to achieve impact
Qualification
Required
Bachelor's Degree
3+ years demonstrated Sales or Commercial experience or a combination of pharmaceutical, healthcare, scientific, clinical, institutional or related industry
Proven leadership capabilities and/or people management experience
A valid driver's license and safe driving record
Demonstrate a strong understanding of the Cardiovascular Renal Metabolic pharmaceutical products, disease states, and treatment guidelines within the specialty care setting
Possess and demonstrate a solid grasp of sales metrics, market analysis, and budget management within the specialty care environment
Understand and identify HCP needs
Share insights to guide Brand Strategy
Actively engage in coaching and development of sales representatives to enhance their performance and professional growth including in field with customer engagement
Cultivate a collaborative and performance-driven team environment, setting clear expectations and providing necessary support for sales representatives to excel
Actively seek out opportunities for growth, leveraging market insights and customer feedback to drive innovative sales strategies
Enable the team to gain access via multiple selling channels across accounts, leveraging relevant technology to achieve impact
Preferred
Clinical Acumen: Extensive understanding of specialized pharmaceutical products, disease states, and treatment guidelines relevant to specific medical specialties
Business Acumen: Deep understanding of the targeted and specialized markets, including specialty clinics, hospital departments, and specialist healthcare providers, along with associated market access challenges
Coaching Excellence: Expertise in coaching to engage with specialist physicians, key opinion leaders, and healthcare teams to effectively communicate the value of specialized treatments and address unique clinical needs of patients
Build High-Performing Teams: Proven ability to drive accountability and set direction aligned to business priorities to build high-performing teams
Growth and Innovation Mindset: Ability to foster a growth mindset and learning agility by leveraging new technology and data insights
Benefits
Qualified retirement programs
Paid time off (i.e., vacation, holiday, and leaves)
Health, dental, and vision coverage in accordance with the terms of the applicable plans
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.
Funding
Current Stage
Public CompanyTotal Funding
$5.26B2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
Leadership Team
Recent News
2026-01-09
2026-01-09
News Powered by Cision
2026-01-08
Company data provided by crunchbase